Antitumor Immunomodulatory Activity of Allogenic Bone Marrow Cells on TiNi Scaffold

被引：0
|
作者：
Kokorev, O. V. [1 ]
Hodorenko, V. N. [1 ]
Cherdyntseva, N. V. [2 ]
Gunther, V. E. [1 ]
机构：
[1] Tomsk State Univ, Tomsk 634050, Russia
[2] Tomsk Canc Res Inst, Tomsk 634050, Russia
来源：
PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS (PC'16) | 2016年 / 1760卷
关键词：
NITI;
D O I：
10.1063/1.4960248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The present study was undertaken to evaluate the feasibility of modulation of anti-tumor response by allogenic bone marrow cell transplantation into porous TiNi-based scaffold. Transplantation of bone marrow cells into porous TiNi-based scaffold leads to antitumor (35%) and antimetastatic (55%) effects. The lifetime of tumor-bearing animals and implanted allogenic bone marrow cells in incubator of TiNi increases up to 60%. The possible mechanisms of the effect of allogenic cells on tumor process are the stimulation of endogenous effectors of antitumor immunity.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Antitumor activity of immunomodulatory antibodies
    Korman, Alan J.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [22] Reconstruction of Human Mandibular Continuity Defects With Allogenic Scaffold and Autologous Marrow Mesenchymal Stem Cells
    Zamiri, Barbad
    Shahidi, Shoaleh
    Eslaminejad, Mohamadreza Baghaban
    Khoshzaban, Ahad
    Gholami, Mehdi
    Bahramnejad, Emad
    Moghadasali, Reza
    Mardpour, Soura
    Aghdami, Nasser
    JOURNAL OF CRANIOFACIAL SURGERY, 2013, 24 (04) : 1292 - 1297
  • [23] Immunomodulatory Effects of Bone-Marrow Mesenchymal Stem Cells in Rheumatoid Arthitis: Influence of Disease Activity
    Fernandez-Gutierrez, Benjamin
    Ramon Lamas, Jose
    Lopiz, Yaiza
    Lajas, Cristina
    Alcazar, Lydia A.
    Rodriguez-Rodriguez, Luis
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] Scaffold design for artificial tissue with bone marrow stem cells
    Noreikaite, Aurelija
    Antanaviciute, Ieva
    Mikalayeva, Valeryia
    Darinskas, Adas
    Tamulevicius, Tomas
    Adomaviciute, Erika
    Simatonis, Linas
    Akramiene, Dalia
    Stankevicius, Edgaras
    MEDICINA-LITHUANIA, 2017, 53 (03): : 203 - 210
  • [25] Bone marrow-derived mesenchymal stem cells protect allogenic islets
    高流芳
    ChinaMedicalAbstracts(Surgery), 2012, 21 (01) : 53 - 54
  • [26] TREATMENT OF BONE-MARROW APLASIA BY ALLOGENIC MARROW GRAFT
    GLUCKMAN, E
    BUSSEL, A
    BENBUNAN, M
    BROQUET, MA
    SCHAISON, G
    DAUSSET, J
    BERNARD, J
    NOUVELLE PRESSE MEDICALE, 1975, 4 (16): : 1177 - 1182
  • [27] Bone marrow stem cells and biological scaffold for bone repair in aging and disease
    Srouji, S
    Livne, E
    MECHANISMS OF AGEING AND DEVELOPMENT, 2005, 126 (02) : 281 - 287
  • [28] Bone marrow progenitor cells enriched scaffold biological behavior in bone repair
    Olsson, Debora Cristina
    Pippi, Ney Luis
    Tognoli, Guilherme Kanciukaits
    Raiser, Aleeu Gaspar
    CIENCIA RURAL, 2008, 38 (08): : 2403 - 2412
  • [29] CYCLOSPORIN IN ALLOGENIC BONE-MARROW TRANSPLANTATION
    KLINGEMANN, HG
    STORB, R
    INTERNIST, 1985, 26 (09): : 569 - 574
  • [30] Allogenic bone marrow transplantation in multiple sclerosis
    Jeffery, DR
    Alshami, E
    NEUROLOGY, 1998, 50 (04) : A147 - A147
12345